nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—IMPDH1—Nucleotide Metabolism—POLD1—uterine cancer	0.0143	0.129	CbGpPWpGaD
Ribavirin—IMPDH1—Nucleotide Metabolism—RRM2—uterine cancer	0.0119	0.107	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—CDKN1C—uterine cancer	0.0117	0.105	CbGpPWpGaD
Ribavirin—ENPP1—uterine cervix—uterine cancer	0.00997	0.0348	CbGeAlD
Ribavirin—Cytarabine—POLD1—uterine cancer	0.00954	0.611	CrCbGaD
Ribavirin—ENPP1—decidua—uterine cancer	0.0095	0.0332	CbGeAlD
Ribavirin—NT5C2—myometrium—uterine cancer	0.00936	0.0327	CbGeAlD
Ribavirin—ENPP1—renal system—uterine cancer	0.00932	0.0326	CbGeAlD
Ribavirin—ENPP1—uterus—uterine cancer	0.00831	0.029	CbGeAlD
Ribavirin—SLC28A3—mammalian vulva—uterine cancer	0.00766	0.0267	CbGeAlD
Ribavirin—IMPDH1—myometrium—uterine cancer	0.0076	0.0265	CbGeAlD
Ribavirin—ENPP1—female reproductive system—uterine cancer	0.00747	0.0261	CbGeAlD
Ribavirin—NT5C2—uterine cervix—uterine cancer	0.00728	0.0254	CbGeAlD
Ribavirin—NT5C2—smooth muscle tissue—uterine cancer	0.00708	0.0247	CbGeAlD
Ribavirin—NT5C2—decidua—uterine cancer	0.00694	0.0242	CbGeAlD
Ribavirin—NT5C2—renal system—uterine cancer	0.00681	0.0238	CbGeAlD
Ribavirin—ENPP1—female gonad—uterine cancer	0.00679	0.0237	CbGeAlD
Ribavirin—NT5C2—endometrium—uterine cancer	0.00659	0.023	CbGeAlD
Ribavirin—NT5C2—mammalian vulva—uterine cancer	0.00637	0.0222	CbGeAlD
Ribavirin—Clofarabine—RRM2—uterine cancer	0.00608	0.389	CrCbGaD
Ribavirin—NT5C2—uterus—uterine cancer	0.00607	0.0212	CbGeAlD
Ribavirin—ADK—myometrium—uterine cancer	0.00599	0.0209	CbGeAlD
Ribavirin—SLC28A3—female gonad—uterine cancer	0.00597	0.0208	CbGeAlD
Ribavirin—ENPP1—Insulin Signaling—MAP3K4—uterine cancer	0.00591	0.0534	CbGpPWpGaD
Ribavirin—IMPDH1—uterine cervix—uterine cancer	0.00591	0.0206	CbGeAlD
Ribavirin—IMPDH1—smooth muscle tissue—uterine cancer	0.00574	0.0201	CbGeAlD
Ribavirin—IMPDH1—decidua—uterine cancer	0.00563	0.0197	CbGeAlD
Ribavirin—IMPDH1—renal system—uterine cancer	0.00553	0.0193	CbGeAlD
Ribavirin—NT5C2—female reproductive system—uterine cancer	0.00546	0.019	CbGeAlD
Ribavirin—IMPDH1—endometrium—uterine cancer	0.00535	0.0187	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—RRM2—uterine cancer	0.0053	0.0478	CbGpPWpGaD
Ribavirin—IMPDH1—mammalian vulva—uterine cancer	0.00517	0.0181	CbGeAlD
Ribavirin—SLC29A1—myometrium—uterine cancer	0.0051	0.0178	CbGeAlD
Ribavirin—NT5C2—female gonad—uterine cancer	0.00496	0.0173	CbGeAlD
Ribavirin—NT5C2—vagina—uterine cancer	0.00493	0.0172	CbGeAlD
Ribavirin—IMPDH1—uterus—uterine cancer	0.00493	0.0172	CbGeAlD
Ribavirin—NT5C2—Nucleotide metabolism—RRM2—uterine cancer	0.00471	0.0425	CbGpPWpGaD
Ribavirin—ADK—uterine cervix—uterine cancer	0.00466	0.0163	CbGeAlD
Ribavirin—ADK—smooth muscle tissue—uterine cancer	0.00453	0.0158	CbGeAlD
Ribavirin—ADK—decidua—uterine cancer	0.00444	0.0155	CbGeAlD
Ribavirin—IMPDH1—female reproductive system—uterine cancer	0.00443	0.0155	CbGeAlD
Ribavirin—ENPP1—lymph node—uterine cancer	0.00437	0.0153	CbGeAlD
Ribavirin—ADK—renal system—uterine cancer	0.00436	0.0152	CbGeAlD
Ribavirin—ADK—endometrium—uterine cancer	0.00421	0.0147	CbGeAlD
Ribavirin—ADK—mammalian vulva—uterine cancer	0.00408	0.0142	CbGeAlD
Ribavirin—IMPDH1—female gonad—uterine cancer	0.00403	0.0141	CbGeAlD
Ribavirin—IMPDH1—vagina—uterine cancer	0.00401	0.014	CbGeAlD
Ribavirin—SLC29A1—uterine cervix—uterine cancer	0.00397	0.0139	CbGeAlD
Ribavirin—IMPDH1—Nucleotide metabolism—RRM2—uterine cancer	0.00384	0.0347	CbGpPWpGaD
Ribavirin—SLC29A1—decidua—uterine cancer	0.00378	0.0132	CbGeAlD
Ribavirin—SLC29A1—renal system—uterine cancer	0.00371	0.013	CbGeAlD
Ribavirin—SLC29A1—endometrium—uterine cancer	0.00359	0.0125	CbGeAlD
Ribavirin—ADK—Nucleotide metabolism—RRM2—uterine cancer	0.00357	0.0322	CbGpPWpGaD
Ribavirin—ADK—female reproductive system—uterine cancer	0.00349	0.0122	CbGeAlD
Ribavirin—SLC29A1—mammalian vulva—uterine cancer	0.00347	0.0121	CbGeAlD
Ribavirin—SLC29A1—uterus—uterine cancer	0.00331	0.0115	CbGeAlD
Ribavirin—ENPP1—Endochondral Ossification—IGF1R—uterine cancer	0.00323	0.0292	CbGpPWpGaD
Ribavirin—NT5C2—lymph node—uterine cancer	0.00319	0.0111	CbGeAlD
Ribavirin—ADK—female gonad—uterine cancer	0.00318	0.0111	CbGeAlD
Ribavirin—ADK—vagina—uterine cancer	0.00316	0.011	CbGeAlD
Ribavirin—SLC29A1—female reproductive system—uterine cancer	0.00297	0.0104	CbGeAlD
Ribavirin—SLC29A1—female gonad—uterine cancer	0.00271	0.00944	CbGeAlD
Ribavirin—SLC29A1—vagina—uterine cancer	0.00269	0.00939	CbGeAlD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—MTHFR—uterine cancer	0.00268	0.0242	CbGpPWpGaD
Ribavirin—IMPDH1—lymph node—uterine cancer	0.00259	0.00904	CbGeAlD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—uterine cancer	0.00218	0.0197	CbGpPWpGaD
Ribavirin—ADK—lymph node—uterine cancer	0.00204	0.00713	CbGeAlD
Ribavirin—SLC29A1—lymph node—uterine cancer	0.00174	0.00607	CbGeAlD
Ribavirin—ENPP1—Insulin Signaling—SOCS3—uterine cancer	0.00167	0.0151	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—IGF1R—uterine cancer	0.00155	0.014	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—VEGFA—uterine cancer	0.0014	0.0127	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00106	0.00956	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—uterine cancer	0.00102	0.00919	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—SRD5A2—uterine cancer	0.000905	0.00817	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SRD5A2—uterine cancer	0.000905	0.00817	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NDUFB11—uterine cancer	0.000905	0.00817	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NDUFB11—uterine cancer	0.000905	0.00817	CbGpPWpGaD
Ribavirin—ENPP1—Endochondral Ossification—AKT1—uterine cancer	0.000895	0.00808	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKR1B10—uterine cancer	0.00084	0.00759	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000789	0.00713	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PTEN—uterine cancer	0.000746	0.00674	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SRD5A2—uterine cancer	0.000738	0.00666	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—NDUFB11—uterine cancer	0.000738	0.00666	CbGpPWpGaD
Ribavirin—ENPP1—Disease—RNF43—uterine cancer	0.000696	0.00629	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NDUFB11—uterine cancer	0.000686	0.00619	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SRD5A2—uterine cancer	0.000686	0.00619	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AKR1B1—uterine cancer	0.000654	0.00591	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKR1B1—uterine cancer	0.000654	0.00591	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—STAR—uterine cancer	0.000654	0.00591	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—STAR—uterine cancer	0.000654	0.00591	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKR1C1—uterine cancer	0.000573	0.00518	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—STAR—uterine cancer	0.000533	0.00482	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKR1B1—uterine cancer	0.000533	0.00482	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—PIK3CA—uterine cancer	0.000526	0.00475	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—POLD1—uterine cancer	0.000513	0.00464	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—POLD1—uterine cancer	0.000513	0.00464	CbGpPWpGaD
Ribavirin—ENPP1—Disease—DCN—uterine cancer	0.000496	0.00448	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKR1B1—uterine cancer	0.000496	0.00448	CbGpPWpGaD
Ribavirin—ADK—Metabolism—STAR—uterine cancer	0.000496	0.00448	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—HRAS—uterine cancer	0.000487	0.0044	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKR1C1—uterine cancer	0.00048	0.00434	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AKR1C1—uterine cancer	0.00048	0.00434	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKR1C3—uterine cancer	0.000441	0.00399	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HMGA1—uterine cancer	0.00043	0.00388	CbGpPWpGaD
Ribavirin—ENPP1—Insulin Signaling—AKT1—uterine cancer	0.00043	0.00388	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—RRM2—uterine cancer	0.000428	0.00387	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—RRM2—uterine cancer	0.000428	0.00387	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—POLD1—uterine cancer	0.000419	0.00378	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—DCN—uterine cancer	0.000416	0.00375	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—DCN—uterine cancer	0.000416	0.00375	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FBXW7—uterine cancer	0.000393	0.00355	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKR1C1—uterine cancer	0.000391	0.00354	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP11A1—uterine cancer	0.000391	0.00354	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP11A1—uterine cancer	0.000391	0.00354	CbGpPWpGaD
Ribavirin—ADK—Metabolism—POLD1—uterine cancer	0.000389	0.00351	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKR1C3—uterine cancer	0.00037	0.00334	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AKR1C3—uterine cancer	0.00037	0.00334	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKR1C1—uterine cancer	0.000364	0.00329	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—RRM2—uterine cancer	0.000349	0.00315	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—DCN—uterine cancer	0.000339	0.00306	CbGpPWpGaD
Ribavirin—ADK—Metabolism—RRM2—uterine cancer	0.000324	0.00293	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CYP11A1—uterine cancer	0.000319	0.00288	CbGpPWpGaD
Ribavirin—ADK—Metabolism—DCN—uterine cancer	0.000315	0.00284	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CDKN2B—uterine cancer	0.000308	0.00278	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKR1C3—uterine cancer	0.000301	0.00272	CbGpPWpGaD
Ribavirin—ADK—Metabolism—CYP11A1—uterine cancer	0.000297	0.00268	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—STK11—uterine cancer	0.000288	0.0026	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—CYP19A1—uterine cancer	0.000288	0.0026	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CYP19A1—uterine cancer	0.000288	0.0026	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—STK11—uterine cancer	0.000288	0.0026	CbGpPWpGaD
Ribavirin—ENPP1—Disease—SMAD3—uterine cancer	0.000281	0.00254	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKR1C3—uterine cancer	0.00028	0.00253	CbGpPWpGaD
Ribavirin—ENPP1—Disease—FGFR2—uterine cancer	0.000268	0.00242	CbGpPWpGaD
Ribavirin—ENPP1—Disease—MTHFR—uterine cancer	0.000258	0.00233	CbGpPWpGaD
Ribavirin—Neutropenia—Epirubicin—uterine cancer	0.000246	0.000419	CcSEcCtD
Ribavirin—Abdominal distension—Doxorubicin—uterine cancer	0.000245	0.000417	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000244	0.000416	CcSEcCtD
Ribavirin—Asthma—Doxorubicin—uterine cancer	0.000243	0.000415	CcSEcCtD
Ribavirin—Influenza—Doxorubicin—uterine cancer	0.000243	0.000415	CcSEcCtD
Ribavirin—Pollakiuria—Epirubicin—uterine cancer	0.000243	0.000414	CcSEcCtD
Ribavirin—Photosensitivity reaction—Epirubicin—uterine cancer	0.00024	0.000409	CcSEcCtD
Ribavirin—Paraesthesia—Etoposide—uterine cancer	0.00024	0.000408	CcSEcCtD
Ribavirin—Weight increased—Epirubicin—uterine cancer	0.000239	0.000408	CcSEcCtD
Ribavirin—Pancreatitis—Doxorubicin—uterine cancer	0.000239	0.000406	CcSEcCtD
Ribavirin—Weight decreased—Epirubicin—uterine cancer	0.000238	0.000405	CcSEcCtD
Ribavirin—Dyspnoea—Etoposide—uterine cancer	0.000238	0.000405	CcSEcCtD
Ribavirin—Hyperglycaemia—Epirubicin—uterine cancer	0.000237	0.000404	CcSEcCtD
Ribavirin—Somnolence—Etoposide—uterine cancer	0.000237	0.000404	CcSEcCtD
Ribavirin—Angina pectoris—Doxorubicin—uterine cancer	0.000237	0.000404	CcSEcCtD
Ribavirin—Pneumonia—Epirubicin—uterine cancer	0.000236	0.000402	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—STK11—uterine cancer	0.000235	0.00212	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—CYP19A1—uterine cancer	0.000235	0.00212	CbGpPWpGaD
Ribavirin—Infestation NOS—Epirubicin—uterine cancer	0.000235	0.000399	CcSEcCtD
Ribavirin—Infestation—Epirubicin—uterine cancer	0.000235	0.000399	CcSEcCtD
Ribavirin—Vomiting—Dactinomycin—uterine cancer	0.000234	0.000399	CcSEcCtD
Ribavirin—Bronchitis—Doxorubicin—uterine cancer	0.000234	0.000399	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000233	0.000396	CcSEcCtD
Ribavirin—Rash—Dactinomycin—uterine cancer	0.000232	0.000396	CcSEcCtD
Ribavirin—Decreased appetite—Etoposide—uterine cancer	0.000232	0.000395	CcSEcCtD
Ribavirin—Renal failure—Epirubicin—uterine cancer	0.000231	0.000393	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Etoposide—uterine cancer	0.00023	0.000392	CcSEcCtD
Ribavirin—Fatigue—Etoposide—uterine cancer	0.00023	0.000392	CcSEcCtD
Ribavirin—Neuropathy peripheral—Epirubicin—uterine cancer	0.00023	0.000392	CcSEcCtD
Ribavirin—Stomatitis—Epirubicin—uterine cancer	0.000229	0.000389	CcSEcCtD
Ribavirin—Jaundice—Epirubicin—uterine cancer	0.000229	0.000389	CcSEcCtD
Ribavirin—Constipation—Etoposide—uterine cancer	0.000228	0.000389	CcSEcCtD
Ribavirin—Pain—Etoposide—uterine cancer	0.000228	0.000389	CcSEcCtD
Ribavirin—Conjunctivitis—Epirubicin—uterine cancer	0.000228	0.000388	CcSEcCtD
Ribavirin—Urinary tract infection—Epirubicin—uterine cancer	0.000228	0.000388	CcSEcCtD
Ribavirin—Neutropenia—Doxorubicin—uterine cancer	0.000228	0.000388	CcSEcCtD
Ribavirin—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000226	0.000385	CcSEcCtD
Ribavirin—Pollakiuria—Doxorubicin—uterine cancer	0.000225	0.000383	CcSEcCtD
Ribavirin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000222	0.000378	CcSEcCtD
Ribavirin—Hepatobiliary disease—Epirubicin—uterine cancer	0.000222	0.000378	CcSEcCtD
Ribavirin—Weight increased—Doxorubicin—uterine cancer	0.000222	0.000377	CcSEcCtD
Ribavirin—Epistaxis—Epirubicin—uterine cancer	0.000221	0.000377	CcSEcCtD
Ribavirin—Weight decreased—Doxorubicin—uterine cancer	0.00022	0.000375	CcSEcCtD
Ribavirin—Sinusitis—Epirubicin—uterine cancer	0.00022	0.000375	CcSEcCtD
Ribavirin—Feeling abnormal—Etoposide—uterine cancer	0.00022	0.000375	CcSEcCtD
Ribavirin—Hyperglycaemia—Doxorubicin—uterine cancer	0.00022	0.000374	CcSEcCtD
Ribavirin—Nausea—Dactinomycin—uterine cancer	0.000219	0.000373	CcSEcCtD
Ribavirin—Pneumonia—Doxorubicin—uterine cancer	0.000218	0.000372	CcSEcCtD
Ribavirin—ADK—Metabolism—CYP19A1—uterine cancer	0.000218	0.00197	CbGpPWpGaD
Ribavirin—ADK—Metabolism—STK11—uterine cancer	0.000218	0.00197	CbGpPWpGaD
Ribavirin—Gastrointestinal pain—Etoposide—uterine cancer	0.000218	0.000372	CcSEcCtD
Ribavirin—Infestation NOS—Doxorubicin—uterine cancer	0.000217	0.00037	CcSEcCtD
Ribavirin—Infestation—Doxorubicin—uterine cancer	0.000217	0.00037	CcSEcCtD
Ribavirin—NT5C2—Metabolism—MTHFR—uterine cancer	0.000216	0.00195	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—MTHFR—uterine cancer	0.000216	0.00195	CbGpPWpGaD
Ribavirin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000215	0.000366	CcSEcCtD
Ribavirin—Bradycardia—Epirubicin—uterine cancer	0.000214	0.000365	CcSEcCtD
Ribavirin—Renal failure—Doxorubicin—uterine cancer	0.000213	0.000363	CcSEcCtD
Ribavirin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000213	0.000362	CcSEcCtD
Ribavirin—Urticaria—Etoposide—uterine cancer	0.000212	0.000361	CcSEcCtD
Ribavirin—Haemoglobin—Epirubicin—uterine cancer	0.000212	0.00036	CcSEcCtD
Ribavirin—Stomatitis—Doxorubicin—uterine cancer	0.000212	0.00036	CcSEcCtD
Ribavirin—Jaundice—Doxorubicin—uterine cancer	0.000212	0.00036	CcSEcCtD
Ribavirin—Rhinitis—Epirubicin—uterine cancer	0.000211	0.00036	CcSEcCtD
Ribavirin—Abdominal pain—Etoposide—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Body temperature increased—Etoposide—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Conjunctivitis—Doxorubicin—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Urinary tract infection—Doxorubicin—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Haemorrhage—Epirubicin—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Hepatitis—Epirubicin—uterine cancer	0.000211	0.000359	CcSEcCtD
Ribavirin—Hypoaesthesia—Epirubicin—uterine cancer	0.00021	0.000357	CcSEcCtD
Ribavirin—Pharyngitis—Epirubicin—uterine cancer	0.000209	0.000356	CcSEcCtD
Ribavirin—Urinary tract disorder—Epirubicin—uterine cancer	0.000208	0.000354	CcSEcCtD
Ribavirin—Oedema peripheral—Epirubicin—uterine cancer	0.000207	0.000353	CcSEcCtD
Ribavirin—Connective tissue disorder—Epirubicin—uterine cancer	0.000207	0.000352	CcSEcCtD
Ribavirin—Urethral disorder—Epirubicin—uterine cancer	0.000206	0.000352	CcSEcCtD
Ribavirin—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000205	0.00035	CcSEcCtD
Ribavirin—Epistaxis—Doxorubicin—uterine cancer	0.000205	0.000349	CcSEcCtD
Ribavirin—Sinusitis—Doxorubicin—uterine cancer	0.000204	0.000347	CcSEcCtD
Ribavirin—Visual impairment—Epirubicin—uterine cancer	0.000203	0.000346	CcSEcCtD
Ribavirin—Erythema multiforme—Epirubicin—uterine cancer	0.000199	0.000339	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—uterine cancer	0.000198	0.000338	CcSEcCtD
Ribavirin—Eye disorder—Epirubicin—uterine cancer	0.000197	0.000335	CcSEcCtD
Ribavirin—Hypersensitivity—Etoposide—uterine cancer	0.000197	0.000335	CcSEcCtD
Ribavirin—Tinnitus—Epirubicin—uterine cancer	0.000196	0.000334	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—uterine cancer	0.000196	0.000333	CcSEcCtD
Ribavirin—Flushing—Epirubicin—uterine cancer	0.000195	0.000333	CcSEcCtD
Ribavirin—Cardiac disorder—Epirubicin—uterine cancer	0.000195	0.000333	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—uterine cancer	0.000195	0.000333	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—uterine cancer	0.000195	0.000332	CcSEcCtD
Ribavirin—Haemorrhage—Doxorubicin—uterine cancer	0.000195	0.000332	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—uterine cancer	0.000194	0.00033	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—uterine cancer	0.000193	0.000329	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—uterine cancer	0.000192	0.000328	CcSEcCtD
Ribavirin—Oedema peripheral—Doxorubicin—uterine cancer	0.000192	0.000327	CcSEcCtD
Ribavirin—Asthenia—Etoposide—uterine cancer	0.000191	0.000326	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—uterine cancer	0.000191	0.000326	CcSEcCtD
Ribavirin—Angiopathy—Epirubicin—uterine cancer	0.000191	0.000325	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—uterine cancer	0.000191	0.000325	CcSEcCtD
Ribavirin—Immune system disorder—Epirubicin—uterine cancer	0.00019	0.000324	CcSEcCtD
Ribavirin—Mediastinal disorder—Epirubicin—uterine cancer	0.00019	0.000323	CcSEcCtD
Ribavirin—Chills—Epirubicin—uterine cancer	0.000189	0.000322	CcSEcCtD
Ribavirin—Pruritus—Etoposide—uterine cancer	0.000189	0.000322	CcSEcCtD
Ribavirin—Arrhythmia—Epirubicin—uterine cancer	0.000188	0.00032	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—uterine cancer	0.000188	0.00032	CcSEcCtD
Ribavirin—Alopecia—Epirubicin—uterine cancer	0.000186	0.000317	CcSEcCtD
Ribavirin—Mental disorder—Epirubicin—uterine cancer	0.000184	0.000314	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—uterine cancer	0.000184	0.000314	CcSEcCtD
Ribavirin—Erythema—Epirubicin—uterine cancer	0.000183	0.000312	CcSEcCtD
Ribavirin—Malnutrition—Epirubicin—uterine cancer	0.000183	0.000312	CcSEcCtD
Ribavirin—Diarrhoea—Etoposide—uterine cancer	0.000183	0.000311	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—uterine cancer	0.000182	0.00031	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—uterine cancer	0.000182	0.000309	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—uterine cancer	0.000181	0.000308	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—uterine cancer	0.000181	0.000308	CcSEcCtD
Ribavirin—Flatulence—Epirubicin—uterine cancer	0.000181	0.000308	CcSEcCtD
Ribavirin—Tension—Epirubicin—uterine cancer	0.00018	0.000306	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—uterine cancer	0.000179	0.000306	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—uterine cancer	0.000178	0.000303	CcSEcCtD
Ribavirin—Back pain—Epirubicin—uterine cancer	0.000177	0.000302	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—uterine cancer	0.000177	0.000301	CcSEcCtD
Ribavirin—Dizziness—Etoposide—uterine cancer	0.000176	0.000301	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—MTHFR—uterine cancer	0.000176	0.00159	CbGpPWpGaD
Ribavirin—Muscle spasms—Epirubicin—uterine cancer	0.000176	0.0003	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—uterine cancer	0.000176	0.0003	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—uterine cancer	0.000176	0.000299	CcSEcCtD
Ribavirin—Chills—Doxorubicin—uterine cancer	0.000175	0.000298	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—uterine cancer	0.000174	0.000296	CcSEcCtD
Ribavirin—Vision blurred—Epirubicin—uterine cancer	0.000173	0.000294	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—uterine cancer	0.000172	0.000293	CcSEcCtD
Ribavirin—Mental disorder—Doxorubicin—uterine cancer	0.000171	0.000291	CcSEcCtD
Ribavirin—Ill-defined disorder—Epirubicin—uterine cancer	0.00017	0.00029	CcSEcCtD
Ribavirin—Vomiting—Etoposide—uterine cancer	0.00017	0.000289	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—uterine cancer	0.00017	0.000289	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—uterine cancer	0.00017	0.000289	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—uterine cancer	0.000169	0.000289	CcSEcCtD
Ribavirin—ENPP1—Disease—ERBB2—uterine cancer	0.000169	0.00152	CbGpPWpGaD
Ribavirin—Agitation—Epirubicin—uterine cancer	0.000168	0.000287	CcSEcCtD
Ribavirin—Rash—Etoposide—uterine cancer	0.000168	0.000287	CcSEcCtD
Ribavirin—Dermatitis—Etoposide—uterine cancer	0.000168	0.000286	CcSEcCtD
Ribavirin—Headache—Etoposide—uterine cancer	0.000167	0.000285	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—uterine cancer	0.000167	0.000285	CcSEcCtD
Ribavirin—Tension—Doxorubicin—uterine cancer	0.000166	0.000283	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—uterine cancer	0.000166	0.000283	CcSEcCtD
Ribavirin—Malaise—Epirubicin—uterine cancer	0.000165	0.000282	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—uterine cancer	0.000165	0.000281	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—uterine cancer	0.000165	0.00028	CcSEcCtD
Ribavirin—Syncope—Epirubicin—uterine cancer	0.000164	0.00028	CcSEcCtD
Ribavirin—Leukopenia—Epirubicin—uterine cancer	0.000164	0.000279	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—uterine cancer	0.000164	0.000279	CcSEcCtD
Ribavirin—ADK—Metabolism—MTHFR—uterine cancer	0.000164	0.00148	CbGpPWpGaD
Ribavirin—Muscle spasms—Doxorubicin—uterine cancer	0.000163	0.000278	CcSEcCtD
Ribavirin—Palpitations—Epirubicin—uterine cancer	0.000162	0.000276	CcSEcCtD
Ribavirin—Loss of consciousness—Epirubicin—uterine cancer	0.000161	0.000274	CcSEcCtD
Ribavirin—Cough—Epirubicin—uterine cancer	0.00016	0.000272	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—uterine cancer	0.00016	0.000272	CcSEcCtD
Ribavirin—Convulsion—Epirubicin—uterine cancer	0.000159	0.00027	CcSEcCtD
Ribavirin—Nausea—Etoposide—uterine cancer	0.000159	0.00027	CcSEcCtD
Ribavirin—Hypertension—Epirubicin—uterine cancer	0.000158	0.00027	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000157	0.000268	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—uterine cancer	0.000157	0.000267	CcSEcCtD
Ribavirin—ENPP1—Disease—CDKN1B—uterine cancer	0.000156	0.00141	CbGpPWpGaD
Ribavirin—Arthralgia—Epirubicin—uterine cancer	0.000156	0.000266	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—uterine cancer	0.000156	0.000266	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—uterine cancer	0.000156	0.000266	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—uterine cancer	0.000156	0.000265	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—uterine cancer	0.000156	0.000265	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000155	0.000264	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—uterine cancer	0.000154	0.000263	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—uterine cancer	0.000153	0.00026	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—uterine cancer	0.000153	0.00026	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—uterine cancer	0.000152	0.00026	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—uterine cancer	0.000152	0.000259	CcSEcCtD
Ribavirin—Leukopenia—Doxorubicin—uterine cancer	0.000152	0.000259	CcSEcCtD
Ribavirin—Confusional state—Epirubicin—uterine cancer	0.000151	0.000257	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—uterine cancer	0.00015	0.000255	CcSEcCtD
Ribavirin—Oedema—Epirubicin—uterine cancer	0.00015	0.000255	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—uterine cancer	0.00015	0.000255	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—uterine cancer	0.000149	0.000254	CcSEcCtD
Ribavirin—Cough—Doxorubicin—uterine cancer	0.000148	0.000252	CcSEcCtD
Ribavirin—ENPP1—Disease—CTNNB1—uterine cancer	0.000148	0.00133	CbGpPWpGaD
Ribavirin—Shock—Epirubicin—uterine cancer	0.000147	0.000251	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—uterine cancer	0.000147	0.00025	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—uterine cancer	0.000147	0.00025	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—uterine cancer	0.000146	0.000249	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—uterine cancer	0.000146	0.000249	CcSEcCtD
Ribavirin—Tachycardia—Epirubicin—uterine cancer	0.000146	0.000249	CcSEcCtD
Ribavirin—Skin disorder—Epirubicin—uterine cancer	0.000145	0.000247	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—uterine cancer	0.000145	0.000246	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—uterine cancer	0.000144	0.000246	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—uterine cancer	0.000144	0.000246	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—uterine cancer	0.000144	0.000246	CcSEcCtD
Ribavirin—Anxiety—Doxorubicin—uterine cancer	0.000144	0.000245	CcSEcCtD
Ribavirin—ENPP1—Disease—PTEN—uterine cancer	0.000144	0.0013	CbGpPWpGaD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000143	0.000244	CcSEcCtD
Ribavirin—Discomfort—Doxorubicin—uterine cancer	0.000143	0.000243	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—uterine cancer	0.000143	0.000243	CcSEcCtD
Ribavirin—Dry mouth—Doxorubicin—uterine cancer	0.000141	0.00024	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—uterine cancer	0.00014	0.000238	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—uterine cancer	0.00014	0.000238	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—uterine cancer	0.000138	0.000236	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000138	0.000236	CcSEcCtD
Ribavirin—ENPP1—Disease—EP300—uterine cancer	0.000137	0.00124	CbGpPWpGaD
Ribavirin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000136	0.000232	CcSEcCtD
Ribavirin—Shock—Doxorubicin—uterine cancer	0.000136	0.000232	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—uterine cancer	0.000136	0.000231	CcSEcCtD
Ribavirin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000136	0.000231	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—uterine cancer	0.000135	0.00023	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—uterine cancer	0.000135	0.00023	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—uterine cancer	0.000134	0.000229	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—uterine cancer	0.000134	0.000229	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000134	0.000228	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—uterine cancer	0.000133	0.000227	CcSEcCtD
Ribavirin—Somnolence—Epirubicin—uterine cancer	0.000133	0.000226	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—uterine cancer	0.000132	0.000225	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—uterine cancer	0.000132	0.000224	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—uterine cancer	0.00013	0.000221	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—uterine cancer	0.000129	0.00022	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000129	0.00022	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—uterine cancer	0.000129	0.00022	CcSEcCtD
Ribavirin—ENPP1—Disease—NRAS—uterine cancer	0.000128	0.00116	CbGpPWpGaD
Ribavirin—Constipation—Epirubicin—uterine cancer	0.000128	0.000218	CcSEcCtD
Ribavirin—Pain—Epirubicin—uterine cancer	0.000128	0.000218	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000126	0.000215	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—uterine cancer	0.000125	0.000213	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—uterine cancer	0.000124	0.000212	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—uterine cancer	0.000123	0.00021	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—uterine cancer	0.000123	0.00021	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—uterine cancer	0.000123	0.00021	CcSEcCtD
Ribavirin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000122	0.000208	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—uterine cancer	0.000122	0.000208	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PTEN—uterine cancer	0.00012	0.00109	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—uterine cancer	0.00012	0.00109	CbGpPWpGaD
Ribavirin—Decreased appetite—Doxorubicin—uterine cancer	0.00012	0.000205	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00012	0.000204	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—uterine cancer	0.000119	0.000203	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—uterine cancer	0.000119	0.000202	CcSEcCtD
Ribavirin—Constipation—Doxorubicin—uterine cancer	0.000118	0.000202	CcSEcCtD
Ribavirin—Pain—Doxorubicin—uterine cancer	0.000118	0.000202	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—uterine cancer	0.000118	0.000201	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—uterine cancer	0.000118	0.000201	CcSEcCtD
Ribavirin—NT5C2—Metabolism—EP300—uterine cancer	0.000115	0.00104	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—EP300—uterine cancer	0.000115	0.00104	CbGpPWpGaD
Ribavirin—Feeling abnormal—Doxorubicin—uterine cancer	0.000114	0.000194	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000113	0.000193	CcSEcCtD
Ribavirin—ENPP1—Disease—KRAS—uterine cancer	0.00011	0.000997	CbGpPWpGaD
Ribavirin—Hypersensitivity—Epirubicin—uterine cancer	0.00011	0.000188	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—uterine cancer	0.00011	0.000187	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—uterine cancer	0.000109	0.000186	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—uterine cancer	0.000109	0.000186	CcSEcCtD
Ribavirin—Asthenia—Epirubicin—uterine cancer	0.000107	0.000183	CcSEcCtD
Ribavirin—Pruritus—Epirubicin—uterine cancer	0.000106	0.00018	CcSEcCtD
Ribavirin—Diarrhoea—Epirubicin—uterine cancer	0.000102	0.000174	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—uterine cancer	0.000102	0.000174	CcSEcCtD
Ribavirin—ENPP1—Disease—PIK3CA—uterine cancer	0.000101	0.000916	CbGpPWpGaD
Ribavirin—Asthenia—Doxorubicin—uterine cancer	9.93e-05	0.000169	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—uterine cancer	9.89e-05	0.000168	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—PTEN—uterine cancer	9.82e-05	0.000886	CbGpPWpGaD
Ribavirin—Pruritus—Doxorubicin—uterine cancer	9.79e-05	0.000167	CcSEcCtD
Ribavirin—Vomiting—Epirubicin—uterine cancer	9.51e-05	0.000162	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—uterine cancer	9.47e-05	0.000161	CcSEcCtD
Ribavirin—Rash—Epirubicin—uterine cancer	9.43e-05	0.000161	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—uterine cancer	9.42e-05	0.00016	CcSEcCtD
Ribavirin—ENPP1—Disease—HRAS—uterine cancer	9.38e-05	0.000847	CbGpPWpGaD
Ribavirin—Headache—Epirubicin—uterine cancer	9.37e-05	0.00016	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—EP300—uterine cancer	9.36e-05	0.000845	CbGpPWpGaD
Ribavirin—Dizziness—Doxorubicin—uterine cancer	9.15e-05	0.000156	CcSEcCtD
Ribavirin—ADK—Metabolism—PTEN—uterine cancer	9.13e-05	0.000824	CbGpPWpGaD
Ribavirin—Nausea—Epirubicin—uterine cancer	8.89e-05	0.000151	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—uterine cancer	8.8e-05	0.00015	CcSEcCtD
Ribavirin—Rash—Doxorubicin—uterine cancer	8.73e-05	0.000149	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—uterine cancer	8.72e-05	0.000148	CcSEcCtD
Ribavirin—ADK—Metabolism—EP300—uterine cancer	8.7e-05	0.000786	CbGpPWpGaD
Ribavirin—Headache—Doxorubicin—uterine cancer	8.67e-05	0.000148	CcSEcCtD
Ribavirin—ENPP1—Metabolism—PIK3CA—uterine cancer	8.49e-05	0.000767	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PIK3CA—uterine cancer	8.49e-05	0.000767	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKT1—uterine cancer	8.29e-05	0.000748	CbGpPWpGaD
Ribavirin—Nausea—Doxorubicin—uterine cancer	8.22e-05	0.00014	CcSEcCtD
Ribavirin—NT5C2—Metabolism—AKT1—uterine cancer	6.94e-05	0.000627	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKT1—uterine cancer	6.94e-05	0.000627	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PIK3CA—uterine cancer	6.92e-05	0.000625	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PIK3CA—uterine cancer	6.44e-05	0.000581	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKT1—uterine cancer	5.66e-05	0.000511	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKT1—uterine cancer	5.26e-05	0.000475	CbGpPWpGaD
